A detailed history of Invesco Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 625,179 shares of AXSM stock, worth $54.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
625,179
Previous 557,861 12.07%
Holding current value
$54.4 Million
Previous $44.9 Million 25.09%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$78.93 - $95.84 $5.31 Million - $6.45 Million
67,318 Added 12.07%
625,179 $56.2 Million
Q2 2024

Aug 13, 2024

BUY
$65.72 - $80.5 $20.5 Million - $25.1 Million
312,208 Added 127.09%
557,861 $44.9 Million
Q1 2024

May 14, 2024

BUY
$69.39 - $97.64 $13.8 Million - $19.5 Million
199,490 Added 432.14%
245,653 $19.6 Million
Q4 2023

Feb 12, 2024

SELL
$57.42 - $83.61 $934,682 - $1.36 Million
-16,278 Reduced 26.07%
46,163 $3.67 Million
Q3 2023

Nov 13, 2023

SELL
$69.25 - $82.21 $7.56 Million - $8.97 Million
-109,131 Reduced 63.61%
62,441 $4.36 Million
Q2 2023

Aug 11, 2023

BUY
$58.41 - $90.35 $6.49 Million - $10 Million
111,045 Added 183.46%
171,572 $12.3 Million
Q1 2023

May 12, 2023

SELL
$58.39 - $75.0 $4.61 Million - $5.92 Million
-78,932 Reduced 56.6%
60,527 $3.73 Million
Q4 2022

Feb 13, 2023

SELL
$39.94 - $79.72 $1.26 Million - $2.52 Million
-31,591 Reduced 18.47%
139,459 $10.8 Million
Q3 2022

Nov 14, 2022

BUY
$36.06 - $69.85 $5.73 Million - $11.1 Million
158,821 Added 1298.72%
171,050 $7.63 Million
Q2 2022

Aug 15, 2022

SELL
$21.74 - $46.75 $5,217 - $11,220
-240 Reduced 1.92%
12,229 $469,000
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $1,327 - $2,317
56 Added 0.45%
12,469 $516,000
Q4 2021

Feb 14, 2022

SELL
$30.7 - $43.36 $36,594 - $51,685
-1,192 Reduced 8.76%
12,413 $469,000
Q3 2021

Nov 15, 2021

SELL
$19.91 - $68.26 $3 Million - $10.3 Million
-150,778 Reduced 91.72%
13,605 $448,000
Q2 2021

Aug 17, 2021

BUY
$50.63 - $73.5 $1.63 Million - $2.37 Million
32,250 Added 24.41%
164,383 $11.1 Million
Q1 2021

May 17, 2021

SELL
$55.91 - $81.44 $14.9 Million - $21.7 Million
-266,959 Reduced 66.89%
132,133 $7.48 Million
Q4 2020

Feb 16, 2021

SELL
$66.31 - $86.52 $1.88 Million - $2.46 Million
-28,396 Reduced 6.64%
399,092 $32.5 Million
Q3 2020

Nov 16, 2020

SELL
$68.34 - $85.84 $4.86 Million - $6.11 Million
-71,151 Reduced 14.27%
427,488 $30.5 Million
Q2 2020

Aug 14, 2020

SELL
$49.87 - $98.69 $7.96 Million - $15.7 Million
-159,583 Reduced 24.24%
498,639 $41 Million
Q1 2020

May 15, 2020

BUY
$41.2 - $101.31 $1.93 Million - $4.75 Million
46,863 Added 7.67%
658,222 $38.7 Million
Q4 2019

Feb 14, 2020

SELL
$16.71 - $106.24 $5.65 Million - $35.9 Million
-337,946 Reduced 35.6%
611,359 $63.2 Million
Q3 2019

Nov 14, 2019

BUY
$20.24 - $29.16 $2.87 Million - $4.13 Million
141,796 Added 17.56%
949,305 $19.2 Million
Q2 2019

Aug 14, 2019

SELL
$13.46 - $25.75 $3.27 Million - $6.26 Million
-242,969 Reduced 23.13%
807,509 $20.8 Million
Q1 2019

May 15, 2019

BUY
$2.63 - $16.34 $2.76 Million - $17.2 Million
1,050,478 New
1,050,478 $14.9 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.